➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Mallinckrodt
Moodys
Colorcon
McKinsey

Last Updated: October 18, 2021

DrugPatentWatch Database Preview

Patent: 7,932,240

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 7,932,240
Title:Phosphadiazine HCV polymerase inhibitors IV
Abstract: Provided herein are phosphadiazine polymerase inhibitor, for example, of any of Formulas IV, IV\', I\'\', II\'\', or IVa, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.
Inventor(s): Dousson; Cyril (Canet, FR), Surleraux; Dominique (Wauthier-Braine, BE), Paparin; Jean-Laurent (Vendemian, FR), Pierra; Claire (Montarnaud, FR), Roland; Arlene (Marsillargues, FR)
Assignee: Idenix Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:12/198,895
Patent Claims:see list of patent claims

Details for Patent 7,932,240

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Vidara Therapeutics Research Ltd ACTIMMUNE interferon gamma-1b VIAL; SINGLE-USE 103836 1999-02-25 ⤷  Free Forever Trial Idenix Pharmaceuticals, Inc. (Cambridge, MA) 2027-08-31 RX search
Serono Inc REBIF interferon beta-1a SYRINGE 103780 2002-03-07 ⤷  Free Forever Trial Idenix Pharmaceuticals, Inc. (Cambridge, MA) 2027-08-31 RX search
Biogen AVONEX interferon beta-1a VIAL 103628 1996-05-17 ⤷  Free Forever Trial Idenix Pharmaceuticals, Inc. (Cambridge, MA) 2027-08-31 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Mallinckrodt
AstraZeneca
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.